Automated measurement of transplantable solid tumors using digital electronic calipers interfaced to a microcomputer John F. WorzallaJesse R. BewleyGerald B. Grindey Preclinical Studies Pages: 241 - 251
Activity of datelliptium acetate (NSC 311152; SR 95156A) against solid tumors of mice Patricia Mucci-LoRussoLisa PolinThomas H. Corbett Preclinical Studies Pages: 253 - 261
Combination of flavone acetic acid (FAA) with adriamycin, cis-platinum and difluoromethylornithine (DFMO) in vitro against human colon cancer cells Sarabjit S. NeelamAlvise BernabeiGordon D. Luk Preclinical Studies Pages: 263 - 268
Phase I trial of intravenous vinzolidine (LY 104208) given on a biweekly dosing schedule Daniel R. BudmanWilli KreisVincent Vinciguerra Phase I Studies Pages: 269 - 274
Phase I study of idarubicin administered orally on a daily × 3 schedule David J. StewartShailendra VermaBetty Fontaine Phase I Studies Pages: 275 - 281
Activity of intravenous menogaril in patients with previously untreated metastatic breast cancer Elizabeth A. EisenhauerKathleen I. PritchardJoseph L. Pater Phase II Studies Pages: 283 - 287
A phase II study of menogaril (NSC-269148) in colorectal carcinoma Robert P. WhiteheadRobert H. EarhartJames S. Ungerleider Phase II Studies Pages: 295 - 297
Phase II study of 10-ethyl-10-deaza-aminopterin (10-EdAM; CGP 30 694) for stage IIIB or IV non-small cell lung cancer Jin S. LeeHerman I. LibshitzWaun K. Hong Phase II Studies Pages: 299 - 304
A phase II study of mitoxantrone in advanced gastric cancer J. A. LeviP. O. GillP. Presgrave Phase II Studies Pages: 305 - 306
Phase II study of continuous infusion recombinant gamma interferon in renal carcinoma J. Philip KueblerPhyllis J. GoodmanJulie A. Kish Phase II Studies Pages: 307 - 309
A phase II trial of echinomycin in metastatic cervix carcinoma T. HakesM. MarkmanM. Phillips Phase II Studies Pages: 311 - 312
Bisantrene in advanced, hormone-resistant carcinoma of the prostate: An Illinois Cancer Council phase II study Nicholas J. VogelzangVictor J. LanzottiRichard R. Blough Phase II Studies Pages: 313 - 315
Phase II study of Fenretinide (N-[4-Hydroxyphenyl]retinamide) in advanced breast cancer and melanoma Manuel R. ModianoWilliam S. DaltonFrank L. Meyskens Jr. Phase II Studies Pages: 317 - 319
Phase II trial of carboplatin and vinblastine in adenocarcinoma of the stomach David GinnDavid KelsenGordon Magill Phase II Studies Pages: 321 - 324
Phase II study of tallysomycin S10b in patients with advanced head and neck cancer Claude NicaiseW. K. HongI. Krakoff Phase II Studies Pages: 325 - 328
Esorubicin (deoxydoxorubicin) has low grade activity in malignant melanoma Howard HochsterMyla HuntThomas Smith Phase II Studies Pages: 329 - 332
Phase II study of esorubicin (4 ′ deoxydoxorubicin) in anthracycline naive patients with ovarian cancer Michael D. GreenJames L. SpeyerE. Mark Beckman Phase II Studies Pages: 333 - 336